Pricing Log in Create free account

Werewolf Therapeutics, Inc. (HOWL) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

Werewolf Therapeutics, Inc. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. Werewolf Therapeutics, Inc. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($49.3M and $48.5M). Mereo BioPharma Group plc - Sponsored ADR has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Mereo BioPharma Group plc - Sponsored ADR leads on 9 and Werewolf Therapeutics, Inc. on 3.

Valuation

Metric HOWL MREO Biotechnology median
P/E n/m n/m 8.50
P/S 1.95 n/m 9.71
P/B 2.92 1.68 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.94 n/m 9.21
Earnings yield (74.49%) (58.20%) (33.15%)
Free cash flow yield (62.73%) (53.23%) (25.50%)

Profitability

Metric HOWL MREO Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) (67.85%) (56.36%)
Return on assets (59.31%) (57.73%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HOWL MREO Biotechnology median
Revenue growth (TTM) (5.21%) — 6.02%
EPS growth (last fiscal year) 18.40% 10.16% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL MREO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 5.88 4.72
Net debt to EBITDA 0.97 1.04 0.96

Dividend

Metric HOWL MREO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HOWL MREO Biotechnology median
Market cap 48.46m 49.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack